CHINA RESOURCES SANJIU MEDICAL & PHARMACEUTICAL CO., LTD.

Andere Sprachen China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Aktien

000999

CNE0000011K8

000999

Pharmazeutika

Schlusskurs Shenzhen S.E. Andere Börsenplätze 12.12.2025			% 5 Tage	Veränd. 1. Jan.
28.28 ^CNY	+0.25%		-0.04%	-17.09%

09.12.	CR Sanjius Yiqi Qingfei-Granulat in Chinas Krankenversicherungsverzeichnis aufgenommen	MT
24.10.	China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. legt Ergebnisse für die ersten neun Monate bis zum 30. September 2025 vor	CI

Andere Sprachen

CR Sanjiu's Yiqi Qingfei Granules Placed on China's Medical Insurance List	09.12.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	24.10.
China Resources Sanjiu Medical & Pharmaceutical Q3 net profit down 4.3% y/y	24.10.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Announces 2025 Interim Profit Distribution Plan to Be Implemented (A Shares), Payable on October 17, 2025	10.10.
CR Sanjiu to Invest 10 Billion Yuan in Bank Wealth Management Products	18.09.
China Resources Sanjiu Medical & Pharma to invest in wealth management products	17.09.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Approves Cash Dividend for 2025	02.09.
CR Sanjiu Medical & Pharmaceutical's Attributable Profit Slides 24%; Shares Fall 3%	18.08.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Proposes Interim Cash Dividend for 2025	18.08.
China Resources Sanjiu Medical & Pharmaceutical H1 net profit down 24.3% Y/Y	15.08.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	15.08.
HELP Therapeutics and China Resources Sanjiu Pharmaceutical Company Announce Strategic Partnership to Co-Develop and Commercialize the Investigational Cell Therapy HiCM-188 in Mainland China	16.06.
CR Sanjiu Partners with CR Power on Renewable Energy Project	15.05.
China Energy Projects Limited and Cr Sanjiu Group Enter into the 2025 Cooperation Agreement	14.05.
China Resources Sanjiu Medical & Pharma's Q1 Net Profit Down 6.9% Y/Y	28.04.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025	28.04.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Approves Cash Dividend for 2024 (A Shares), Payable on 06 June 2025	18.04.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. completed the acquisition of 28% stake in Tasly Pharmaceutical Group Co., Ltd from a group of shareholders.	27.03.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Announces Final Dividend Proposal for 2024	13.03.
CR Sanjiu Logs 18% Boost in 2024 Profit	13.03.
China Resources Sanjiu's 2024 Net Profit Up 18.1% Y/Y	12.03.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	12.03.
China Resources Sanjiu To Buy 28% Stake in Tasly	28.02.
China Resources Pharmaceutical's Shenzhen Listed Subsidiary Records 18% Higher Net Attributable Profit for 2024	10.02.
China Resources Sanjiu Gets SASAC Approval for Tasly Pharmaceutical Stake Acquisition	07.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Aktien

000999

CNE0000011K8

000999

Pharmazeutika

Andere Sprachen

Filter